INTRODUCTION
The incidence of microbial infections have been increasing day by day in worldwide. Many antibacterial agents are in use against a wide range of infectious diseases 1, 2 . However, the resistance to existing drugs is still a serious problem threat to global public health. This situation leads medicinal chemists to investigate newly synthesized more potent antimicrobial drugs 3 . Among many antibacterial agents, nitrofuran containing drugs (Figure 1 . furazolidone, nitrofurantoin nitrofurazone and furaltadone) have been widely used for protection against microbial and protozoal infections especially associated with food contaminations 4 . The nitrofurans are characterized by a 5-nitro-2-furanyl group. First synthesized drug nitrofurazone, 5-nitro-2-furaldehyde semicarbazone, is still being used molecule due to its antitrypanosomal activity as well as antibac-terial potential to treat burns topically 5 . However, mutagenic/carcinogenic toxic effects of this molecule were detected for the antimicrobial and anti-protozoal applications 6 . Therefore, prodrug approach was suggested to increase biological activity and decrease toxicity along with improving the physico-chemical properties 7 . For this purpose, many 5-nitrofuryl derivatives have been extensively studied for the treatment of various microbial infections [8] [9] [10] [11] [12] and these compounds are determined to act via producing oxidative stress on the parasite which leads to death of the microbe 13 .
Addition to all, nitrofuran agents have been developed through combining thiosemicarbazone moiety and different heterocyclic rings. Thiosemicarbazones and their derivatives are important compounds known with many biological properties especially as chemotherapeutic agents [14] [15] [16] [17] [18] . Their cyclization products, (4-aryl-thiazol-2-yl)hydrazines are also widely studied derivatives due to their numerous pharmacological applications and varied biological activities [19] [20] [21] . Also, thiazole containing compounds have attracted broad interest because of their synthesis ease of reaction and their capability to easily furnish valuable chemotherapeutics such as anticancer, antibacterial, antifungal, and antiprotozoal agents 22 .
Considering the reported data, we have described six novel compounds combining (4-aryl-thiazol-2-yl)hydrazine and 5-nitrofuryl moieties which we based on well-known antibacterial agent, nitrofurazone. The antibacterial activity of the compounds have been investigated against various microorganisms compared with standard drug.
METHODOLOGY Chemistry
Melting points were determined by MP90 digital melting point apparatus (Mettler Toledo, OH) and were uncorrected. Spectroscopic data were obtained by instruments: Bruker Tensor 27 IR spectrophotometer; 1 H NMR (nuclear magnetic resonance) Bruker DPX-300 FT-NMR spectrometer, 13 C NMR, Bruker DPX 75 MHz spectrometer (Bruker Bioscience, Billerica, MA, USA); M+1 peaks were determined by Shimadzu LC/MS ITTOF system (Shimadzu, Tokyo, Japan).
Preparation of 5-nitrofuran-2-carbaldehyde thiosemicarbazone (1)
A mixture of thiosemicarbazide (0.27 g, 3 mmol) and 5-nitro-2-furaldehyde diacetate (3 mmol) in ethanol (20 mL) was refluxed for 3 h. After keeping the solution at 0 °C overnight, the precipitated raw product was filtered off and recrystallized from ethanol to afford corresponding thiosemicarbazone compound (1).
Preparation of 4-aryl-2-[2-((5-nitrofuran-2-yl)methylene) hydrazinyl]thiazole derivatives (2a-f)
5-Nitro-2-furaldehyde thiosemicarbazone (1) (0.2 mmol) and appropriate α-bromoarylethanone derivative (0.16 g, 0.80 mmol) were stirred in ethanol at room temperature. The progress of the reaction was monitored by TLC. The mixture was filtered, the product was dried and recrystallized from ethanol, to give target compounds (2a-f). The minimum inhibitory concentrations (MIC) was defined as the lowest concentration of compound giving complete inhibition of visible growth and the minimum bactericidal concentration (MBC) was defined as the lowest concentration of the compound to completely kill bacteria. Nitrofurazone was used as positive control. According to values of the controls, the results were evaluated. Each experiment was replicated twice.
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RESULTS AND DISCUSSION
Chemistry
In this study, 4-aryl-2-[2-((5-nitrofuran-2-yl)methylene)hydrazinyl]thiazole derivatives (2a-f) were synthesized with a two-step synthetic procedure as shown Scheme 1. Characteristic infra-red stretching bands belong to amine (NH) and nitro (NO 2 ) groups were detected at 3121-3112 cm -1 and about 1550, 1340 cm -1 , respectively. In 1 H NMR spectra, peaks of azomethine (-CH=N) and amine protons were detected in range 7.99-7.89 ppm and 11.85-12.89 ppm, respectively. OH protons of 2a-c were detected at about 9.49-10.84 ppm as broad singlet peaks. In the 13 C NMR spectra, all carbons were observed at 102.26-169.11 ppm range, correctly. Molecular ion peaks were also determined in agreement with molecular weights of the compounds.
Biology
Final compounds (2a-f) were screened to determine their antimicrobial activities against totally seven Gram negative and Gram positive bacteria; E. coli, S. typhi, E. faecalis, S. aureus, S. epidermidis, L. monocytogenes and B. cereus. MIC and MBC were identified for standart drug nitrofurazone and all compounds. As were represented in Table 1 , The MIC and MBC values were found between 0.5-2 mg/mL and higher for the 2a-c, whereas both of the values were found as 1 mg/mL and higher for nitrofurazone.
Among the hydroxylated compounds (2a-c), compound 2a exhibited the highest activity against B. cereus (MIC=0.5 mg/mL, MBC=1 mg/mL). Besides, it showed same potency to nitrofurazone (MIC: 1 mg/mL) against E. coli and E. faecalis. Compound 2b did not show prominent antibacterial activity which had MIC and MBC values 2 mg/mL and higher against all tested bacteria. Another hydroxyl containing compound 2c showed same antibacterial potency to standard drug against three bacteria, S. aureus, S. typhi and L. monocytogenes.
Regarding to compounds 2d-e with pyridine moiety, they exhibited significant activity with a higher potency than hydroxylated compounds (2a-c). Compound 2d including 2-pyridyl moiety showed two-fold antibacterial potency against B. cereus (MIC and MBC: 0.5 mg/mL) compared to nitrofurazone. It exhbited same potency to standard drug against E. coli and S. epidermis. Also, the lowest concentrations of compound 2d caused inhibition growth of bacteria (MIC) were found as 1 mg/mL whereas the lowest concentrations of the compound caused completely death of bacteria (MBC) were found higher than the highest tested concentration (>2 mg/mL) against E. faecalis, S. aureus, S. typhi and L. monocytogenes. MIC values for compound 2e were found between 0.5-1 mg/ mL whereas MBC values were found as 2 mg/mL. Additionally, compound 2e containing 3-pyridine moiety could be declared as the most active compound with the lowest MIC values among the other compounds. Also, sixth compound 2f bearing 4-pyridyl moiety showed remarkable activity. MIC and MB values were calculated as 0.5 mg/mL against the most susceptible bacteri B. cereus. 
